EVALUASI PENGGUNAAN TERAPI OBAT KARDIOVASKULAR PADA PASIEN HIPERTENSI YANG DIRAWAT DI RSUP DR. M. DJAMIL PADANG
Abstract
Hypertension is one of the major modifiable risk factors associated with cardiovascular disease, and its prevalence and severity increase with age. The purpose of this study was to look at the description of the use of hypertension drug therapy, gender and age level of patients treated at dr. M. Djamil Padang Hospital October-December 2023 period. Data were collected retrospectively from the medical records of hypertensive patients admitted to the internal medicine ward. period October to December 2023 analyzed descriptively. Based on the results of the study of 131 hypertensive patients who were treated at DR. M.Djamil Padang Hospital in the October-December 2023 period, it was concluded that male sex patients were more than female, based on the age of patients with an age range of 56 - 65 years and the use of the most widely used antihypertensive therapy was 3 combinations.References
Centers for Disease Control and Prevention. (2016) ‘Protocol for Controlling Hypertension in Adults.’, p. 2.
Chruściel, P. et al. (2022) ‘Clinical research
Associations between the lipid profile and the development of hypertension in young individuals – the preliminary study’, 18 (1):, pp. 25–35.
Defianna, S.R. et al. (2021) ‘Gender differences in
prevalence and risk factors for hypertension among adult populations: A cross-sectional study in indonesia’, International Journal of Environmental Research and Public Health, 18(12). Available at: https://doi.org/10.3390/ijerph18126259.
Heni Setyoningsih (2022) ‘Hubungan Interaksi Obat Terhadap Efektivitas Obat’, 6(1), pp. 76–88.
Kemenkes (2023) ‘Survei Kesehatan Indonesia
Tahun 2023’, Badan Kebijakan Pembangunan Kesehatan Tim Penyusun Ski 2023 Dalam Angka, pp. 1–68.
Khairiyah, U., Yuswar, M.A. and Purwanti, N.U.
(2022) ‘Pola Penggunaan Obat Antihipertensi Pada Pasien Hipertensi di Instalasi Rawat Jalan Rumah Sakit’, Jurnal Syifa Sciences and Clinical Reasearch (JSSCR), 4(3), pp. 609–617.
El Khoudary, S.R. et al. (2020) ‘Menopause
Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement from the American Heart Association’, Circulation, 142(25), pp. E506–E532. Available at: https://doi.org/10.1161/CIR.000000000000 0912.
Kim, C. et al. (2023) ‘Women’s Reproductive
Milestones and Cardiovascular Disease Risk: A Review of Reports and Opportunities From the CARDIA Study’, Journal of the American Heart Association, 12(5), pp. 1–19. Available at: https://doi.org/10.1161/JAHA.122.028132.
Lauder, L. et al. (2023) ‘Hypertension management
in patients with cardiovascular comorbidities’, European Heart Journal, 44(23), pp. 2066–2077. Available at: https://doi.org/10.1093/eurheartj/ehac395.
Madania et al. (2022) ‘Potensi Interaksi Obat Pasien
Hipertensi Dan Diabetesmelitus Tipe2 Di Instalasi Rawat Jalan Rsud Toto Kabila’, Pharmacoscript, 5(1), pp. 56–62.
Mannan, A. et al. (2022) ‘Association between comorbidity and health-related quality of life in a hypertensive population: a hospital- based study in Bangladesh’, BMC Public Health, 22(1), pp. 1–12. Available at: https://doi.org/10.1186/s12889-022-12562-w.
Marx, N. et al. (2023) ‘2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology’, European Heart Journal, 44(39), pp. 4043–4140.
Mills, K.T., Stefanescu, A. and He, J. (2020) ‘The
global epidemiology of hypertension’, Nature Reviews Nephrology, 16(4), pp. 223– 237. Available at: https://doi.org/10.1038/s41581-019-0244-2.
Neutel, J.M. and Smith, D.H.G. (2020) ‘
Hypertension management: Rationale for triple therapy based on mechanisms of action’, Cardiovascular Therapeutics, 31(5), pp. 251–258. Available at: https://doi.org/10.1111/1755-5922.12015.
Sakti Pambudi, R. and Rista Rini, H. (2024) ‘Indonesian Journal of Pharmacy and Natural Product Potensi Interaksi Penggunaan Obat Antihipertensi di Klinik X Tahun 2023 Potential Interactions with the Use of Antihypertensive Drugs at Clinic X Boyolali in 2023’, 07, pp. 41–46.
Volpe, M., Gallo, G. and Tocci, G. (2020) ‘Trends
in Cardiovascular Medicine New approach to blood pressure control : Triple combination pill ✩’, Trends in Cardiovascular Medicine, 30(2), pp. 72–77. Available at: https://doi.org/10.1016/j.tcm.2019.03.002.
WHO (2023) ‘Afghanistan Albania Hypertension profile’, (2019).
Wierzejska, E. et al. (2020) ‘Systematic review / Meta-analysis A global perspective on the costs of hypertension : a s ystematic review’, Arch Med Sci, 16, pp. 1078–1091.
Zaman, M.A. et al. (2023) ‘Comparing Triple
Combination Drug Therapy and Traditional Monotherapy for Better Survival in Patients With High-Risk Hypertension : A Systematic Review’, 15(7). Available at: https://doi.org/10.7759/cureus.41398.
